⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Smith & Nephew plc and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Smith & Nephew plc
↗Watford, England
Smith & Nephew is a British multinational medical technology company focused on the repair, regeneration, and replacement of soft and hard tissue. The company operates through three primary business units: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management, providing innovative solutions to restore patient health and mobility.
CLASSIFICATION
Company Type:MedTech
Therapeutic Areas:-
Industry:Medical Devices
Sub-Industry:Orthopedics, Sports Medicine, Wound Management
SIZE & FINANCIALS
Employees:10000+
Founded:1856
Ownership:public
Status:operating
STOCK
Exchange:LSE, NYSE
Ticker:SN
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A
Modalities:Medical Devices, Surgical Implants, Wound Care Solutions
Active Trials:85
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Various healthcare providers and surgical centers globally
COMPETITION
Position:Leader
Competitors:Zimmer Biomet, Stryker, DePuy Synthes (Johnson & Johnson), Medtronic
LEADERSHIP
Key Executives:
Deepak Nath - CEO
LINKS
Website:smith-nephew.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Smith & Nephew plc. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.